Harmit S. Kalia, D.O.
Dr. Kalia's clinical and research interests include NAFLD, complications of end stage liver disease and liver transplantation.
1. Kalia H, Lopez PM, Martin P. Treatment of HCV in patients with renal failure. Arch Med Res. 2007 Aug;38(6):628-33. Review.
2. Kalia H, Fabrizi F, Martin P. Hepatitis B virus and renal transplantation. Transplant Rev (Orlando). 2011 Jul;25(3):102-9
3. Bichoupan K, Schwartz JM, Martel-Laferriere V, Giannattasio ER, Marfo K, Odin JA, Liu LU, Schiano TD, Perumalswami P, Bansal M, Gaglio PJ, Kalia H, Dieterich DT, Branch AD, Reinus JF. Effect of fibrosis on adverse events in patients with hepatitis C treated with telaprevir. Aliment Pharmacol Ther. 2014 Jan;39(2):209-16.
Material in this section is provided by individual faculty members who are solely responsible for its accuracy and content.